Rheumatoid Arthritis Dr ahad azami. Rheumatoid Arthritis Systemic Systemic Chronic Chronic Inflammatory Inflammatory Primarily targets the synovium of.

Slides:



Advertisements
Similar presentations
RHEUMATOID ARTHRITIS RA Inson lou. Epidemiology Symptoms signs Labs Diagnosis Treatment.
Advertisements

doc.MUDr. Želmíra Macejová, PhD III. Internal clinic LF UPJŠ
Rheumatoid Arthritis John Imboden MD.
Tests for Rheumatoid Arthritis Chua, Kathleen. Laboratory Findings Rheumatoid factors Antibodies to Cyclic Citrullinated Peptide (Anti-CCP) CBC with differential.
ACR Criteria in Determining Progression of RA StageClinical and Radiologic Criteria Stage 1Early RA No destructive changes observed upon roentgenographic.
In the name of GOD.
RHEUMATOID ARTHRITIS VS OSTEOARTHRITIS Anusha Reddy FY1 General Surgery (UHCW) 25 th Nov 2013.
1 IN THE NAME OF GOD. 2 Rheumatoid Arthritis A chronic multisystem disease Characteristic feature: Persistent inflammatory synovitis Peripheral joints.
IMPROVING EARLY DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS Michael Lockwood, MD, FACP, FACR Rheumatology Indiana University Health Arnett.
CLINICAL CASES. Case 1: Mr. OA Mr. OA: Case Presentation 62-year-old lawyer Mild left knee pain for 3 month, but became worse 1 week ago No swelling.
Diagnosing inflammatory arthritis
RHEUMATOID ARTHRITIS. Chronic multisystem disease of unknown cause Characteristic features: Persistent inflammatory synovitis Involves peripheral joints.
Tena Trbojević Mentor: A. Žmegač Horvat
Rheumatology: OSTEOARTHRITIS RHEUMATOID ARTHRITIS Dr. Meg-angela Christi Amores.
Rheumatoid Arthritis By, Marissa Miuccio.
RA- Epidemiology/ Genetics  Most common inflammatory arthritis  Prevalence: 0.8 % of population ( increasing prevalence with age)  M:F 1:3  Age range:
ARTHRITIS. Osteoarthritis is a degenerative joint disease is the most common joint disorder. It is a frequent part of aging and is an important cause.
Rheumatoid arthritis vs Osteoarthritis Katy Davidson and Hannah Brown.
All About Rheumatoid Arthritis
OA vs RA Alastair Stephens Matt Vreugde. What are the 5 functions of bone? Function SupportProtection Movement Haematopoiesis Mineral Homeostasis.
Management of Rheumatoid Arthritis Morning stiffness Morning stiffness in and around the joints, lasting at least 1 hour before maximal improvement.
Arthritis Osteoarthritis (OA)   Osteoarthritis   Most common form of joint (articular) disease   Previously called degenerative joint disease  Risk.
Rheumatoid Arthritis Anila Malik GPVTS. Aims To cover the following: What is RA? Diagnostic criteria and clinical features Rheumatoid Factor Investigations.
Rheumatoid Arthritis(RA)
Arthritis Hip and Knee Nigel Brewster Aims l Types of arthritis l Symptoms of arthritis l Signs of arthritis l Treatment of arthritis.
Rheumatoid Arthritis of the Cervical Spine Zikou Anastasia Radiology Department University Hospital of Ioannina.
RHEUMATOID ARTHRITIS By: Julie Le and Mary Le 5/2/12 4 th pd.
1031 MD4. Jane is a 45 year old woman, who presents to her doctor complaining of morning stiffness of the joints of her fingers for several weeks now.
Dr. Sarah Ehsan (PT). Topics to be covered in this lecture: Arthritis–arthrosis Fibromyalgia and myofascial pain syndrome Osteoporosis Fractures–post-traumatic.
Orthopaedics Wa’el N. Qa’dan, MSc. Rheumatoid arthritis (RA): It is the commonest cause of chronic inflammatory joint disease. Most typical.
Dr. Maha Arafah  Know the following: ◦ Osteoarthritis: Incidence, Primary and secondary types, pathogenesis and clinical features ◦ Rheumatoid.
Nursing Management: Arthritis and Connective Tissue Diseases
Case #13 Ellen Marie de los Reyes March 15, 2007.
Dr. Mahboob Ur Rahman BSPT,PPDPT,EMBA Chief Physiotherapist HMC Peshawar/ Founder &Chairman Mahboob School of Physiotherapy Hayatabad.
AM Report 11/24/09 Amy Auerbach  Peak onset between 20 and 30 years  Form of spondyloarthritis (cause inflammation around site of ligament insertion.
Osteoarthritis.  Osteoarthritis OA is a degenerative disease of diarthrodial ( synovial ) joints, characterized by  Breakdown of articular cartilage.
DEGENERATIVE JOINT DISEASE = OSTEOARTHRITIS. DEGENERATIVE JOINT DISEASE Degenerative joint disease is chracterized by: 1. pain 2. stiffness 3. loss of.
ARTHRITIS Aaron Calilap Cariane Matela Tyra Wiggins.
RHEUMATOID ARTHRITIS AND REHABILITATION Prof. Dr. Ülkü Akarırmak.
Rheumatoid Questions and Notes on OA and RA. A patient presents with rheumatoid arthritis. On examination of her hands, she has several joint deformities.
Dr. Hanan AL Rayes, MD Consultant Rheumatology
Rheumatoid Arthritis(RA) Dr. Gehan Mohamed. Learning objectives: At the end of this lecture the student should be able to : understand definition,genetic.
IIIB – DOCTOR OF MEDICINE B5 Dr. Tan - Ong. ACR classification criteria Morning stiffness Arthritis of three or more joint areas Arthritis of hand joints.
Adult Medical-Surgical Nursing Musculo-skeletal Module: Rheumatoid Arthritis.
Rheumatology teaching session GP ST2 year 8/9/10.
Rheumatology Connective tissue disease (CTD) is a major focus of rheumatology. Rheumatic disease is any disease or condition involving the musculoskeletal.
Case Discussion Dr. Raid Jastania. What is the outcome of inflammation?
Rheumatoid Arthritis.
Dr. Maha Arafah Dr. Abdulmalik Alsheikh, MD, FRCPC Jan 2012.
Rheumatoid Arthritis and Systemic Lupus Erythematosus.
Please enjoy the show…….. By : Ashlee Kolkow What is RA? Most serious form of arthritis, leading to severe crippling Autoimmune disorder Chronic inflammation.
Rheumatoid Arthritis Christine Aranyi and Rebecca Boon State university of new york institute of technology Pathophysiolog y Rheumatoid Arthritis (RA)
RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.
Pathology for year 2, unit 3 Lecture number 8 & 9. NB: The total number of lectures is 17.
Copyright 2005 Lippincott Williams & Wilkins Chapter 12 Therapeutic Exercise for Arthritis.
Rheumatology Normal Anatomy andPhysiology. Synovial joints: Normal Anatomy 1. Bone: 2. Cartilage: 3. Synovium:
Rheumatoid arthritis (RA).  Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally.
Osteoarthritis vs Rheumatoid Arthritis
Arthritis Hip and Knee Nigel Brewster 1998.
The following diseases are accompanied by changes in the joints:
Arthritis of the Hands.
Tests for Rheumatoid Arthritis
Arthritis All answers are TRUE for the T/F questions.
OSTEOARTHRITIS DEGENERATIVE JOINT DISEASE
Arthritis.
Rheumatoid ARTHRITIS.
RHEUMATOID ARTHRITIS Dr.Fakhir Yousif.
Imaging of joint diseases
54 Osteoarthritis.
Presentation transcript:

Rheumatoid Arthritis Dr ahad azami

Rheumatoid Arthritis Systemic Systemic Chronic Chronic Inflammatory Inflammatory Primarily targets the synovium of diarthrodial joints Primarily targets the synovium of diarthrodial joints Etiology likely combination genetic and environmental Etiology likely combination genetic and environmental

Diarthrodial Joint

Rheumatoid Arthritis Female: male 3:1 Female: male 3:1 4 th -6 th decades of life 4 th -6 th decades of life Symmetric polyarthritis Symmetric polyarthritis Extra-articular manifestations Extra-articular manifestations Subcutaneous nodules/lung nodules Subcutaneous nodules/lung nodules Scleritis Scleritis Vasculitis Vasculitis Felty’s syndrome Felty’s syndrome

Stages of RA Pathogenesis StageSymptomsFindings 1.AntigenNoneNone PresentationNormal X-ray to T Cells to T Cells 2.T and B CellMalaise, Mild,Swelling or Pain Proliferation,Joint Stiffnessof Small Joints AngiogenesisSwellingWrists, Knees in SynoviumNormal, X-ray ACR

Stages of RA Pathogenesis (Continued) StageSymptomsFindings 3.SFPMNJoint Pain,Warm, Swollen AccumulationSwellingJoints, Inc SF Synovial CellAM Stiffness,Soft Tissue ProliferationMalaise,Proliferation, WeaknessLimited ROM, Nodules, Soft Tissue Swelling on X-ray ACR

Stages of RA Pathogenesis (continued) Stage Symptoms Findings 4.Pannus Same as Same as Invasion, Stage 3Stage 3 ChondrocytePeriarticular Activation,Osteopenia, Enzyme Proliferative ActivationPannus on MRI ACR

Stages of RA Pathogenesis (continued) Stage SymptomsFindings 5.Subchondral Same asSame as stage 3 Bone Erosion, Stage 3Plus Instability Pannus Plus LossFlexion Invasion of of FunctionContractures, Cartilage DeformityExtra-Articular StretchedDisease, Early LigamentsErosions and Joint Space Narrowing on X-Ray ACR

Synovium in RA

PIP Swelling

Ulnar Deviation, MCP Swelling, Left Wrist Swelling

Joints involved in RA

Don’t forget the cervical spine!! Instability there can lead to impingement of the spinal cord Don’t forget the cervical spine!! Instability there can lead to impingement of the spinal cord Thoracolumbar, sacroiliac, and distal interphalangeal joints of the hand are not involved Thoracolumbar, sacroiliac, and distal interphalangeal joints of the hand are not involved

Extra-articular Symptoms Patients that are more likely to get are: Patients that are more likely to get are: RF+ RF+ HLA DR4+ HLA DR4+ Male Male

Corneal Melt

Nodules

Pulmonary Nodules

Felty’s Syndrome Seropositive Rheumatoid Arthritis Seropositive Rheumatoid Arthritis Splenomegaly Splenomegaly Granulocytopenia Granulocytopenia ACR

Large Granular Lymphocytes

Labs Can also see nonspecific abnormalities Can also see nonspecific abnormalities High sedimentation rate High sedimentation rate Anemia Anemia Hypergammaglobulinemia Hypergammaglobulinemia Thrombocytosis Thrombocytosis

Rheumatoid Factor Antibodies that recognize Fc portion of IgG Antibodies that recognize Fc portion of IgG Can be IgM, IgG, IgA, IgE Can be IgM, IgG, IgA, IgE 85% of patients with RA over the first 2 years become RF+ 85% of patients with RA over the first 2 years become RF+

Anti-ccp

Radiographic Features Peri-articular osteoporosis Peri-articular osteoporosis Uniform joint space narrowing Uniform joint space narrowing Marginal erosions Marginal erosions Soft tissue swelling Soft tissue swelling Subluxations Subluxations Symmetric Symmetric Cysts Cysts

Synovial Fluid Inflammatory Inflammatory WBCs ,000 WBCs ,000 ≥ 50% neutrophils ≥ 50% neutrophils No crystals No crystals Negative Cultures Negative Cultures

Noninflammatory on left Inflammatory on right

ACR Criteria Morning Stiffness ≥1 hour Morning Stiffness ≥1 hour Soft tissue swelling of ≥ 3 joints observed by physician Soft tissue swelling of ≥ 3 joints observed by physician Swelling of proximal interphalangeal (PIP), metacarpophalangeal (MCP), or wrist joints Swelling of proximal interphalangeal (PIP), metacarpophalangeal (MCP), or wrist joints These signs and symptoms must be present ≥ 6 weeks These signs and symptoms must be present ≥ 6 weeks

ACR Criteria Continued Symmetric Arthritis present for ≥ 6 weeks Symmetric Arthritis present for ≥ 6 weeks Subcutaneous nodules Subcutaneous nodules Positive Rheumatoid Factor Positive Rheumatoid Factor Radiographic Erosions or periarticular osteopenia in hand or wrist joints Radiographic Erosions or periarticular osteopenia in hand or wrist joints Must have ≥4 criteria to meet diagnosis of RA

Criteria for Progression of RA Stage I – Early Stage I – Early No Destructive Changes Osteoporosis on X-Ray Stage II – Moderate Stage II – Moderate Osteoporosis and Slight Subchondral Bone or Cartilage Destruction Cartilage Destruction No Joint Deformaties, Mobility May be Limited Adjacent Muscle Atrophy Adjacent Muscle Atrophy Nodules or Tenosynovitis May be Present ACR

Criteria for Progression of RA (continued) Stage III – Severe Stage III – Severe Osteoporosis and Erosions Deformity Without Ankylosis Extensive Muscle Atrophy Nodules and Tenosynovitis Stage IV – Terminal Stage IV – Terminal Fibrous or Bony Ankylosis Features of Stage III ACR

Management Focused on relieving pain and preventing damage/disability Focused on relieving pain and preventing damage/disability Patient education about the disease is key Patient education about the disease is key Physical Therapy for stretching and range of motion exercises Physical Therapy for stretching and range of motion exercises Occupational Therapy for splints and adaptive devices Occupational Therapy for splints and adaptive devices Surgery Surgery

Rheumatoid Arthritis: Classification of Function Class I: No Limitations Class II: Adequate for Normal Activities Despite Joint Discomfort of Limitation of Movement Class III: Inadequate for Most Self-Care and Occupational Activities Occupational Activities Class IV: Largely or Wholly Unable to Manage Self- Care; Restricted to Bed or Chair ACR

Medicines Non-Steroidal anti-inflammatories (NSAIDS) for symptom control Non-Steroidal anti-inflammatories (NSAIDS) for symptom control Prednisone for quick control of joint inflammation but cannot use long term due to side effects Prednisone for quick control of joint inflammation but cannot use long term due to side effects Osteoporosis, cataracts, weight gain, insulin resistance, dyslipidemias Osteoporosis, cataracts, weight gain, insulin resistance, dyslipidemias

Disease Modifying Anti- rheumatic Agents Drugs that actually control the disease and not just treat symptoms Drugs that actually control the disease and not just treat symptoms Should be used early on in patients Should be used early on in patients Erosions can develop in the joints of patients within the first two years of disease Erosions can develop in the joints of patients within the first two years of disease

Disease Modifying Anti- rheumatic Agents Hydroxychloroquine-for mild disease, takes a long time to reach steady state, very benign in side effect profile Hydroxychloroquine-for mild disease, takes a long time to reach steady state, very benign in side effect profile Sulfasalazine-for mild disease, toxicities include GI upset Sulfasalazine-for mild disease, toxicities include GI upset Azathioprine-for moderate disease, not as modifying as other drugs, cytopenias Azathioprine-for moderate disease, not as modifying as other drugs, cytopenias

Disease Modifying Anti- rheumatic Agents Methotrexate-moderate to severe disease, very successful in preventing erosions, liver toxicities Methotrexate-moderate to severe disease, very successful in preventing erosions, liver toxicities Anti-TNFα agents-used for mod-severe disease, but moving up as first line drug, TB reactivation a concern Anti-TNFα agents-used for mod-severe disease, but moving up as first line drug, TB reactivation a concern

Prognosis RA can shorten the life span 3-18 years RA can shorten the life span 3-18 years Most die from cardiovascular disease, infection or lymphoproliferative disorders Most die from cardiovascular disease, infection or lymphoproliferative disorders Overall RA patients are much better off than at any other time in history due to ongoing research and new meds!! Overall RA patients are much better off than at any other time in history due to ongoing research and new meds!!